CervoMed Inc. Stock Issued During Period, Shares, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CervoMed Inc. stock issued during period, shares, acquisitions for the quarter ending 2023-12-31 was 0.00 shares.
- CervoMed Inc. stock issued during period, shares, acquisitions for the quarter ending 2016-12-31 was 0.00 shares.
- CervoMed Inc. stock issued during period, shares, acquisitions for the quarter ending 2016-09-30 was -16.75M shares.
- CervoMed Inc. stock issued during period, shares, acquisitions for the quarter ending 2016-06-30 was 0.00 shares.
- CervoMed Inc. stock issued during period, shares, acquisitions for fiscal 2023 was 1.36M shares.
- CervoMed Inc. stock issued during period, shares, acquisitions for fiscal 2016 was 1.86M shares.
| Period end | Stock Issued During Period, Shares, Acquisitions 3 month | Stock Issued During Period, Shares, Acquisitions 12 month |
|---|---|---|
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 1.36M shares 10-K · filed 2024-03-29 |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | 1.86M shares 10-K · filed 2018-04-02 |
| 2016-09-30 | -16.75M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | |
| 2016-03-31 | 18.61M shares 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |